• Highest monthly revenue in Company history at $910,767
• Wholesale channel recorded strongest monthly revenue of $340,131
• Continued momentum across all sales channels including Australian grocery, USA Amazon and B2B ingredient sales

The Calmer Co. International Limited (ASX: CCO), a leading consumer packaged goods company specialising in kava and other natural products, has announced its highest monthly revenue in the Company's history, delivering unaudited December 2025 sales of $910,767. This marks the strongest single-month performance since listing. The record monthly performance reflects continued improvement in channel mix and margin profile, supporting the Company's path toward sustainable profitability. The wholesale channel recorded its strongest monthly revenue of $340,131, with year-to-date wholesale sales already exceeding total FY25 annual wholesale revenue in the first half of FY26. The Company also saw continued momentum across all sales channels including Australian grocery, USA Amazon and B2B ingredient sales. Australian retail performance remained robust, led by Fiji Kava® distribution through Coles and Woolworths, while USA sales growth was driven by expanding Amazon product range including tinctures, capsules and flavoured kava shots. B2B ingredient sales were supported by increasing demand for high-kavalactone kava extracts from global partners. The result underpins the Company's trajectory toward breakeven and validates its vertically-integrated 'farm-to-shelf' strategy.

The Company's record monthly revenue of $910,767 in December 2025 represents the highest in the Company's history, with the wholesale channel recording its strongest monthly revenue of $340,131. Year-to-date wholesale sales have already exceeded total FY25 annual wholesale revenue in the first half of FY26.

The Company's momentum across all sales channels, including Australian grocery, USA Amazon and B2B ingredient sales, positions it for sustained, profitable growth in FY26. The recent regulatory advancements in the United States, where the U.S. Food and Drug Administration has confirmed that traditionally prepared kava beverages qualify as food under federal law, provides regulatory certainty and a clearer compliance pathway for kava products in the world's largest consumer market, de-risking broader retail distribution and digitally-led growth.